Vidence and NTT DATA Announce Partnership to Deliver Predictive Analytics in Oncology
Summary
BOCA RATON, Fla. & PLANO, Texas--(BUSINESS WIRE)--Vidence, an oncology informatics company, and NTT DATA Services, a global digital business and IT services leader, today announced a relationship to build advanced artificial intelligence (AI) and machine learning (ML) algorithms to predict patient outcomes, enhance decision-making, and drive clinical trials to advance cancer research and treatment. This unique collaboration will utilize a combination of medical imaging scan, clinical and outcomes data to build a predictive model that will optimize treatment regimens. The original founders of the renowned Cancer Treatment Centers of America (CTCA) created Vidence to set a standard in the industry for high-quality information. With our consultative approach, we leverage deep industry expertise and leading-edge technologies powered by AI, automation and cloud to create practical and scalable solutions that contribute to society and help clients worldwide. This includes consulting, applications, data intelligence and analytics, hybrid infrastructure, workplace, cybersecurity and business process services to help organizations accelerate and sustain value throughout their digital journeys.
Classifications
AskAI Classifications
LabelsLinked Companies
